Like observed for IGF2BP1 (see Figure 1A), the mRNA expression of the 31 identified E2F/IGF2BP1-driven factors was associated with a significantly reduced survival probability across 33 cancers (Figure 6F). This evidence concerns the gene IGF2BP1 and cancer.